1. Home
  2. Southern Africa
  3. South Africa

Catholic priest first in HIV vaccine trials

A Catholic priest on Tuesday became the first person in South Africa to participate in the human trials of an experimental HIV vaccine.

The South African AIDS Vaccine Initiative (SAAVI) announced earlier this week that they were ready begin two separate local trials of the vaccine, Alpha Vax.

Father Kieran Creagh said the Catholic church's efforts against HIV/AIDS, including education and abstinence drives, had fallen short, and he now believed that only medical research could provide a solution.

He told the Associated Press he was so moved by the suffering of people living with HIV/AIDS in South Africa, that he wanted to do something about the pandemic.

With roughly 11 percent of the population living with HIV/AIDS, it is estimated that around 600 to 1,000 South Africans die of AIDS-related illnesses each day.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join